China Resources Boya Bio-pharmaceutical Group Co., Ltd

The company was founded in 1993. It is a blood products platform in China Resources Health. It is a comprehensive pharmaceutical industry group focusing on blood products business, integrating biochemicals, chemicals, APIs, etc., and is one of the few enterprises with a complete range of products in the three categories of human blood albumin, human immunoglobulin, and coagulation factors in the country. The company is mainly engaged in R&D, production and sales of blood products, including three types of products: albumin, immunoglobulins and coagulation factors. The company's products cover 9 varieties of 23 specifications, including human blood albumin, intravenous human immunoglobulin (pH4), and coagulation factors. Corporate honors: It has successively won honorary awards such as Forbes China's Top 100 Potential Listed Companies in 2013, 2014 and 2016, China's Top 50 Listed Companies in 2014, China's Top 100 Listed Companies Most Respected by Investors in 2015, China's Top 150 Listed Companies by Jinniu Value Investors in 2016, and Top 10 Pharmaceutical Companies with the Most Investment Value in 2017.